{"hands_on_practices": [{"introduction": "Systemic Sclerosis (SSc) is a heterogeneous disease with a wide spectrum of clinical manifestations. To standardize its diagnosis for clinical trials and research, the 2013 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) developed a point-based classification system. This first exercise provides hands-on practice in applying these crucial criteria, training you to weigh and synthesize a constellation of clinical signs, organ involvement, and autoantibody profiles to arrive at a classification, just as a rheumatologist would [@problem_id:4902483].", "problem": "A 52-year-old individual presents with features suggestive of systemic sclerosis, including sclerodactyly (skin thickening limited to the fingers and distal to the metacarpophalangeal joints), fingertip pitting scars (without active digital tip ulcers), telangiectasia on the face and hands, abnormal nailfold capillaries on capillaroscopy, Raynaud’s phenomenon, and a positive anti-centromere antibody. There is no skin thickening proximal to the metacarpophalangeal joints, no interstitial lung disease on high-resolution computed tomography, and no pulmonary arterial hypertension on right heart catheterization.\n\nUse the 2013 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for systemic sclerosis, which assign weighted points across domains, with the following foundational rules:\n- The classification score is the sum of weighted points across domains. Within a domain, only the highest applicable item is counted. The domains and weights are:\n  1. Finger skin thickening domain: puffy fingers $2$; sclerodactyly (skin thickening distal to the metacarpophalangeal joints) $4$; skin thickening of both hands extending proximal to the metacarpophalangeal joints $9$. If the proximal item ($9$) is present, this alone is sufficient for classification.\n  2. Fingertip lesions domain: digital tip ulcers $2$; fingertip pitting scars $3$.\n  3. Telangiectasia $2$.\n  4. Abnormal nailfold capillaries $2$.\n  5. Pulmonary arterial hypertension and/or interstitial lung disease $2$.\n  6. Raynaud’s phenomenon $3$.\n  7. Systemic sclerosis-related autoantibodies (anti-centromere, anti-topoisomerase I, or anti–RNA polymerase III) $3$.\n- A total classification score $\\geq 9$ classifies the patient as systemic sclerosis.\n\nCalculate the total classification score $S$ for this patient based on the given features and determine whether the score meets the classification threshold. Report your final answer as a row matrix $\\begin{pmatrix} S & I \\end{pmatrix}$, where $I = 1$ if the criteria are met and $I = 0$ otherwise. No rounding is required, and no units are to be included.", "solution": "The problem requires the calculation of a classification score for systemic sclerosis based on a set of clinical features and a specific scoring system, the 2013 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. The final output should be a row matrix containing the total score and a binary indicator for whether the classification threshold is met.\n\n### Step 1: Extract Givens\n\nThe clinical features of the 52-year-old individual are:\n1.  Sclerodactyly (skin thickening limited to the fingers and distal to the metacarpophalangeal joints).\n2.  No skin thickening proximal to the metacarpophalangeal joints.\n3.  Fingertip pitting scars.\n4.  No active digital tip ulcers.\n5.  Telangiectasia on the face and hands.\n6.  Abnormal nailfold capillaries on capillaroscopy.\n7.  Raynaud’s phenomenon.\n8.  Positive anti-centromere antibody.\n9.  No interstitial lung disease on high-resolution computed tomography.\n10. No pulmonary arterial hypertension on right heart catheterization.\n\nThe 2013 ACR/EULAR classification criteria assign points as follows, with only the highest score within a domain being counted:\n- **Domain 1 (Finger skin thickening):** Puffy fingers ($2$ points); Sclerodactyly ($4$ points); Skin thickening proximal to metacarpophalangeal joints ($9$ points).\n- **Domain 2 (Fingertip lesions):** Digital tip ulcers ($2$ points); Fingertip pitting scars ($3$ points).\n- **Domain 3 (Telangiectasia):** $2$ points.\n- **Domain 4 (Abnormal nailfold capillaries):** $2$ points.\n- **Domain 5 (Pulmonary arterial hypertension and/or interstitial lung disease):** $2$ points.\n- **Domain 6 (Raynaud’s phenomenon):** $3$ points.\n- **Domain 7 (Systemic sclerosis-related autoantibodies):** $3$ points for anti-centromere, anti-topoisomerase I, or anti–RNA polymerase III.\n\nA total score $S \\geq 9$ classifies the patient as having systemic sclerosis. The classification indicator $I$ is $1$ if the criteria are met, and $0$ otherwise.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem is scientifically grounded, well-posed, and objective. It is based on the established 2013 ACR/EULAR classification criteria, a standard tool in rheumatology. The problem provides all necessary data (patient features and scoring rules) to calculate a unique, deterministic score. The language is precise and free of ambiguity or subjective claims. The task is a formal application of a rule-based algorithm, which is a valid logical problem. Therefore, the problem is deemed valid and a solution can be derived.\n\n### Step 3: Calculation of the Total Classification Score\n\nLet $S$ be the total classification score. We will calculate the score by summing the points from each of the seven domains, adhering to the rule that only the highest-scoring item in each domain is counted.\n\n- **Domain 1: Finger skin thickening**\nThe patient has \"sclerodactyly (skin thickening limited to the fingers and distal to the metacarpophalangeal joints)\". The score for this item is $4$. The patient does not have skin thickening proximal to the metacarpophalangeal joints (which would score $9$), nor are \"puffy fingers\" mentioned as the primary finding. Thus, the score for this domain is $4$.\n\n- **Domain 2: Fingertip lesions**\nThe patient has \"fingertip pitting scars\". The score for this item is $3$. The patient does not have active digital tip ulcers (which would score $2$). Since $3 > 2$, the highest applicable score for this domain is $3$.\n\n- **Domain 3: Telangiectasia**\nThe patient has \"telangiectasia on the face and hands\". The score for this item is $2$.\n\n- **Domain 4: Abnormal nailfold capillaries**\nThe patient has \"abnormal nailfold capillaries on capillaroscopy\". The score for this item is $2$.\n\n- **Domain 5: Pulmonary arterial hypertension and/or interstitial lung disease**\nThe patient has \"no interstitial lung disease\" and \"no pulmonary arterial hypertension\". Therefore, no points are awarded for this domain. The score is $0$.\n\n- **Domain 6: Raynaud’s phenomenon**\nThe patient has \"Raynaud’s phenomenon\". The score for this item is $3$.\n\n- **Domain 7: Systemic sclerosis-related autoantibodies**\nThe patient has a \"positive anti-centromere antibody\". This is one of the specific SSc-related autoantibodies listed. The score for this item is $3$.\n\nThe total classification score $S$ is the sum of the points from each domain:\n$$S = (\\text{Score}_{Domain 1}) + (\\text{Score}_{Domain 2}) + (\\text{Score}_{Domain 3}) + (\\text{Score}_{Domain 4}) + (\\text{Score}_{Domain 5}) + (\\text\n{Score}_{Domain 6}) + (\\text{Score}_{Domain 7})$$\n$$S = 4 + 3 + 2 + 2 + 0 + 3 + 3$$\n$$S = 17$$\n\n### Step 4: Determine Classification Status\n\nThe threshold for classification is a total score $S \\geq 9$. The calculated score is $S = 17$.\nSince $17 \\geq 9$, the criteria for classifying the patient as having systemic sclerosis are met.\nTherefore, the indicator variable $I$ is equal to $1$.\n\nThe final answer is to be reported as a row matrix $\\begin{pmatrix} S & I \\end{pmatrix}$.\nSubstituting the calculated values, we get $\\begin{pmatrix} 17 & 1 \\end{pmatrix}$.", "answer": "$$\\boxed{\\begin{pmatrix} 17 & 1 \\end{pmatrix}}$$", "id": "4902483"}, {"introduction": "Once a patient is classified as having SSc, the next step is to assess the extent and severity of the disease. Cutaneous fibrosis is a hallmark feature, and its quantification is essential for monitoring disease progression and response to therapy. This practice introduces the modified Rodnan skin score (mRSS), the gold standard for assessing skin thickness, demonstrating how a systematic, semi-quantitative physical examination can be translated into a valuable clinical endpoint [@problem_id:4902503].", "problem": "A clinician is evaluating a patient with Systemic Sclerosis (SSc) and quantifies cutaneous involvement using the modified Rodnan skin score (mRSS). The mRSS is defined as the sum of palpation-based thickness grades across $17$ standardized body regions, each graded on an ordinal scale $0$ (normal), $1$ (mild), $2$ (moderate), or $3$ (severe). The $17$ regions are: face, anterior chest, abdomen, right and left upper arms, right and left forearms, right and left hands, right and left fingers, right and left thighs, right and left lower legs, and right and left feet. For this assessment, assume any region not explicitly listed has a score of $0$. The regional scores obtained are: face $1$, chest $2$, abdomen $1$, right upper arm $2$, left upper arm $2$, right lower arm $3$, left lower arm $3$, right hand $3$, left hand $3$, right thigh $1$, left thigh $1$, right lower leg $2$, left lower leg $2$, right foot $1$, and left foot $1$.\n\nUsing the formal definition of the mRSS as the sum of the $17$ regional scores, compute the total skin score $T$. Then, interpret disease severity using the following categorical mapping based on total skin score $T$: mild if $0 \\leq T \\leq 14$, moderate if $15 \\leq T \\leq 29$, and severe if $T \\geq 30$. Encode the severity category as a numeric code $S$ where mild $=1$, moderate $=2$, and severe $=3$.\n\nProvide your final answer as two values in a single row matrix, first the total mRSS $T$, second the severity code $S$. No rounding is required.", "solution": "The problem requires the computation of the modified Rodnan skin score (mRSS), denoted as $T$, for a patient with Systemic Sclerosis, and the subsequent determination of a disease severity code, $S$, based on the value of $T$.\n\nFirst, the problem is validated. All givens are extracted and assessed.\n- The definition of the mRSS is the sum of scores from $17$ specified body regions.\n- The scoring for each region is on an ordinal scale from $0$ to $3$.\n- A specific list of scores for $15$ out of the $17$ regions is provided.\n- A rule is given for unlisted regions: their score is $0$.\n- A categorical mapping from the total score $T$ to disease severity (mild, moderate, severe) is defined.\n- A numerical encoding for these severity categories is provided ($S=1, 2, 3$).\nThe problem is scientifically grounded in established rheumatological practice, well-posed with all necessary information, and objective. It contains no contradictions, ambiguities, or factual errors. Therefore, the problem is deemed valid and a solution can be derived.\n\nThe total score $T$ is the sum of the scores from the $17$ anatomical regions. Let $s_i$ be the score for the $i$-th region. Then, the total score is $T = \\sum_{i=1}^{17} s_i$.\n\nThe scores for the $17$ regions are as follows:\n- Face: $1$\n- Anterior Chest: $2$\n- Abdomen: $1$\n- Right Upper Arm: $2$\n- Left Upper Arm: $2$\n- Right Forearm: $3$\n- Left Forearm: $3$\n- Right Hand: $3$\n- Left Hand: $3$\n- Right Thigh: $1$\n- Left Thigh: $1$\n- Right Lower Leg: $2$\n- Left Lower Leg: $2$\n- Right Foot: $1$\n- Left Foot: $1$\n\nThe problem statement lists $15$ scores. The standard mRSS includes $17$ regions. The missing regions from the provided list are the right and left fingers. According to the problem statement, \"any region not explicitly listed has a score of $0$\". Therefore:\n- Right Fingers: $0$\n- Left Fingers: $0$\n\nNow, we can compute the total score $T$ by summing the scores of all $17$ regions:\n$$T = 1 (\\text{face}) + 2 (\\text{chest}) + 1 (\\text{abdomen}) + 2 (\\text{R upper arm}) + 2 (\\text{L upper arm}) + 3 (\\text{R forearm}) + 3 (\\text{L forearm}) + 3 (\\text{R hand}) + 3 (\\text{L hand}) + 0 (\\text{R fingers}) + 0 (\\text{L fingers}) + 1 (\\text{R thigh}) + 1 (\\text{L thigh}) + 2 (\\text{R lower leg}) + 2 (\\text{L lower leg}) + 1 (\\text{R foot}) + 1 (\\text{L foot})$$\n$$T = 1 + 2 + 1 + 2 + 2 + 3 + 3 + 3 + 3 + 0 + 0 + 1 + 1 + 2 + 2 + 1 + 1$$\nSumming these values:\n$$T = (1+2+1) + (2+2) + (3+3) + (3+3) + (0+0) + (1+1) + (2+2) + (1+1)$$\n$$T = 4 + 4 + 6 + 6 + 0 + 2 + 4 + 2$$\n$$T = 8 + 12 + 8$$\n$$T = 28$$\nThe total mRSS is $T=28$.\n\nNext, we determine the disease severity category based on $T$. The criteria are:\n- Mild: $0 \\leq T \\leq 14$\n- Moderate: $15 \\leq T \\leq 29$\n- Severe: $T \\geq 30$\n\nSince $T=28$, the condition $15 \\leq 28 \\leq 29$ is met. Therefore, the disease severity is classified as moderate.\n\nFinally, we encode this severity category into the numeric code $S$. The encoding rules are:\n- Mild $\\rightarrow S=1$\n- Moderate $\\rightarrow S=2$\n- Severe $\\rightarrow S=3$\n\nAs the severity is moderate, the corresponding code is $S=2$.\n\nThe problem asks for the final answer as two values in a single row matrix: the total mRSS $T$ and the severity code $S$.\nThe calculated values are $T=28$ and $S=2$.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n28 & 2\n\\end{pmatrix}\n}\n$$", "id": "4902503"}, {"introduction": "Beyond skin involvement, SSc can affect multiple internal organs, with pulmonary arterial hypertension (PAH) being a leading cause of mortality. Understanding the pathophysiology of this complication is critical. This exercise moves from external signs to internal hemodynamics, guiding you through the calculation of pulmonary vascular resistance ($PVR$) from right heart catheterization data to understand the hemodynamic signature of precapillary pulmonary hypertension, the classic pattern seen in SSc-associated PAH [@problem_id:4902453].", "problem": "A 55-year-old woman with limited cutaneous systemic sclerosis presents with progressive exertional dyspnea. Right heart catheterization at rest yields a mean pulmonary arterial pressure (mPAP) of 30 mmHg, a pulmonary capillary wedge pressure (PCWP) of 10 mmHg, and a thermodilution cardiac output (CO) of 4.0 L/min. Using the hydrodynamic identity that relates pressure gradient to flow and resistance, derive the expression for pulmonary vascular resistance ($PVR$) in terms of $mPAP$, $PCWP$, and $CO$, compute its value for the measurements provided, and then use contemporary hemodynamic definitions to classify the pulmonary hypertension as precapillary or postcapillary and determine whether the pattern is consistent with pulmonary arterial hypertension in systemic sclerosis. Express the final $PVR$ in Wood units and round your answer to two significant figures.", "solution": "The problem is evaluated as scientifically grounded, well-posed, and objective. It provides a realistic clinical scenario with plausible physiological data, requiring the application of fundamental hemodynamic principles. All necessary information is provided, and the questions are specific and answerable. Therefore, the problem is deemed valid and a full solution is provided below.\n\nThe relationship between pressure, flow, and resistance in a fluid system is analogous to Ohm's law in electrical circuits, which states that resistance ($R$) is the ratio of the potential difference ($\\Delta V$) across a component to the current ($I$) flowing through it, i.e., $R = \\Delta V / I$. In hemodynamics, this principle is applied to blood flow through a vascular bed.\n\nThe pulmonary vascular resistance ($PVR$) quantifies the resistance to blood flow through the pulmonary circulation. The pressure gradient ($\\Delta P$) across the pulmonary circuit is the difference between the mean pressure at its inlet, the pulmonary artery, and the mean pressure at its outlet, the left atrium. The flow through the circuit is the cardiac output ($CO$).\n\nThe mean pulmonary arterial pressure ($mPAP$) is the average pressure in the pulmonary artery. The pressure in the left atrium is clinically estimated by the pulmonary capillary wedge pressure ($PCWP$), which is measured by inflating a balloon on the tip of a pulmonary artery catheter, thereby occluding a small pulmonary artery branch and measuring the pressure downstream, which reflects the left atrial pressure.\n\nThus, the pressure gradient across the pulmonary circulation is given by:\n$$\n\\Delta P = mPAP - PCWP\n$$\n\nThe flow through the pulmonary circulation is the cardiac output ($CO$).\n\nFollowing the hydrodynamic identity, the pulmonary vascular resistance ($PVR$) is derived as the ratio of the pressure gradient to the flow:\n$$\nPVR = \\frac{\\Delta P}{CO}\n$$\nSubstituting the expressions for $\\Delta P$ and flow, the formula for $PVR$ is:\n$$\nPVR = \\frac{mPAP - PCWP}{CO}\n$$\n\nNext, we compute the value of $PVR$ for the patient using the data from the right heart catheterization:\n- Mean pulmonary arterial pressure ($mPAP$) = $30$ mmHg\n- Pulmonary capillary wedge pressure ($PCWP$) = $10$ mmHg\n- Thermodilution cardiac output ($CO$) = $4.0$ L/min\n\nSubstituting these values into the derived expression:\n$$\nPVR = \\frac{30 \\text{ mmHg} - 10 \\text{ mmHg}}{4.0 \\text{ L/min}} = \\frac{20 \\text{ mmHg}}{4.0 \\text{ L/min}} = 5.0 \\frac{\\text{mmHg} \\cdot \\text{min}}{\\text{L}}\n$$\n\nThe unit $\\frac{\\text{mmHg} \\cdot \\text{min}}{\\text{L}}$ is defined as a Wood unit ($WU$). Therefore, the patient's $PVR$ is $5.0$ $WU$. This result is already expressed to two significant figures as requested.\n\nNow, we classify the type of pulmonary hypertension ($PH$) using contemporary hemodynamic definitions (based on the 2022 ESC/ERS guidelines).\nFirst, the general definition for $PH$ is an $mPAP > 20$ mmHg at rest. This patient's $mPAP$ is $30$ mmHg, confirming the presence of $PH$.\n\n$PH$ is classified into precapillary and postcapillary forms based on $PCWP$ and $PVR$:\n- **Precapillary PH**: Defined by $mPAP > 20$ mmHg, $PCWP \\le 15$ mmHg, and $PVR > 2$ $WU$.\n- **Postcapillary PH**: Defined by $mPAP > 20$ mmHg and $PCWP > 15$ mmHg. This is further divided into:\n  - Isolated postcapillary $PH$ (Ipc-PH): $PVR \\le 2$ $WU$.\n  - Combined post- and precapillary $PH$ (Cpc-PH): $PVR > 2$ $WU$.\n\nApplying these criteria to the patient's data:\n- $mPAP = 30$ mmHg ($> 20$ mmHg)\n- $PCWP = 10$ mmHg ($\\le 15$ mmHg)\n- $PVR = 5.0$ $WU$ ($> 2$ $WU$)\n\nThe patient's hemodynamic profile perfectly matches the criteria for **precapillary pulmonary hypertension**.\n\nFinally, we determine if this pattern is consistent with pulmonary arterial hypertension ($PAH$) in the context of systemic sclerosis. Systemic sclerosis is a leading cause of connective tissue disease-associated $PAH$ (CTD-PAH), which falls under Group $1$ of the clinical classification of $PH$. The pathognomonic hemodynamic signature of $PAH$ is precapillary $PH$. Therefore, the finding of precapillary $PH$ in a $55$-year-old woman with systemic sclerosis and progressive dyspnea is the expected and classic pattern, strongly suggesting a diagnosis of $PAH$.", "answer": "$$\n\\boxed{5.0}\n$$", "id": "4902453"}]}